Pharmaceutical Exporter in Brazil from India
ANVISA-compliant supply of affordable generics, oncology, specialty medicines, biosimilars and APIs — for Brazilian importers, distributors, hospitals and NGOs.
How to enquire
Getting a quote is quick and simple:
- Share your molecule, quantity and destination country.
- We confirm availability, pricing and lead time.
- We prepare the ANVISA documentation you need.
- You hear back from us within 1 business day.
For licensed buyers & healthcare professionals.
A high-value India–Brazil trade corridor
India is one of the leading pharmaceutical exporters to Brazil, and the relationship has become a key pillar of India–Brazil bilateral trade. For importers, wholesalers, distributors, hospitals and NGOs, India offers high-quality, affordable medicines backed by the largest base of regulator-approved manufacturing facilities outside the United States.
Full-year pharmaceutical exports to Brazil reached approximately US$778 million in FY25, growing more than 17% year-on-year in FY26 — placing Brazil among India's top five export destinations alongside the USA, UK, France and South Africa. Trade is concentrated in APIs, oncology treatments, specialty medicines, biosimilars and complex generics, and India supplies a large share of Brazil's pharmaceutical raw materials.
What India exports to Brazil
Active Ingredients
Bulk APIs and raw pharmaceutical ingredients for Brazilian manufacturers.
Generic Formulations
Cost-effective, quality-assured generics across major therapy areas.
Oncology Treatments
Cancer therapies for hospitals, specialty pharmacies and tenders.
Specialty Medicines
High-value and rare-disease products, including Named Patient supply.
Biosimilars
Affordable biosimilar options for growing Brazilian demand.
Complex Generics
Difficult-to-formulate molecules backed by approved facilities.
ANVISA registration & GMP — non-negotiable
Brazil maintains one of the most rigorous pharmaceutical frameworks in Latin America. Every product must be registered and approved by ANVISA — Brazil's counterpart to the US FDA — and Indian facilities must pass ANVISA's on-site GMP inspections before market entry.
- ANVISA registration & approval for all medicinal products entering Brazil.
- GMP compliance with ANVISA standards and successful on-site inspections.
- Local importer / distributor of record for product liability and market access.
- Certificate of Pharmaceutical Product (CPP) issued in India by CDSCO.
- Documentation: COA, COO, Free Sale Certificates and batch records for customs.
- CDSCO–ANVISA MoU supports smoother regulatory pathways for compliant exporters.
How Indian Generic Medicines supports your Brazil supply
Manufacturer Sourcing
Direct sourcing from leading, accredited Indian manufacturers.
Named Patient Programs
NPP supply for unapproved or hard-to-access medicines, where permitted.
Regulatory & Customs Docs
COA, COO, CPP, FSC and batch records prepared for clearance.
GDP Logistics
Compliant international logistics with cold-chain for sensitive products.
Leading Indian pharmaceutical exporters to Brazil
Indian Generic Medicines (IGM)
A pharmaceutical exporter focused on supplying affordable, high-quality generic and branded medicines to Brazilian importers, distributors, wholesalers and hospitals seeking cost-effective treatment options.
Ikris Pharma Network & The Indian Pharma (TIP)
Global sourcing and export companies facilitating specialty medicines, oncology and hematology therapies, rare-disease treatments and Named Patient Program supply, with regulatory and documentation support.
Ready to source compliant medicines for Brazil?
Tell us your molecule and volume on our contact form — we come back with pricing, lead time and the ANVISA documentation you'll need.
Frequently asked questions
Several Indian companies export to Brazil, including Indian Generic Medicines (IGM), which supports importers, hospitals and distributors with compliant supply.
India's pharmaceutical exports to Brazil reached approximately US$778 million in FY25 and grew more than 17% year-on-year in FY26, making Brazil one of India's top 5 export destinations.
All pharmaceutical products must be registered and approved by ANVISA, Brazil's health regulatory agency. Indian manufacturing facilities must comply with ANVISA's GMP standards and pass ANVISA inspections before market entry.
India exports active pharmaceutical ingredients (APIs), generic formulations, oncology treatments, specialty medicines, biosimilars and complex generics to Brazil.
